94 related articles for article (PubMed ID: 782693)
1. Early history and development of the nitrosoureas.
Schepartz SA
Cancer Treat Rep; 1976 Jun; 60(6):647-9. PubMed ID: 782693
[No Abstract] [Full Text] [Related]
2. Nitrosoureas: a review of experimental antitumor activity.
Schabel FM
Cancer Treat Rep; 1976 Jun; 60(6):665-98. PubMed ID: 782694
[TBL] [Abstract][Full Text] [Related]
3. Historical development and future promise of the nitrosoureas as anticancer agents.
Schabel FM
Cancer Chemother Rep 3; 1973 May; 4(3):3-6. PubMed ID: 4584035
[No Abstract] [Full Text] [Related]
4. Formulation of three nitrosoureas for intravenous use.
Davignon JP; Yang KW; Wood HB; Cradock JC
Cancer Chemother Rep 3; 1973 May; 4(3):7-11. PubMed ID: 4201309
[No Abstract] [Full Text] [Related]
5. Antitumour activity of a new water-soluble nitrosoureido sugar: CY233 (NSC 609224).
Gosse C; Atassi G; Letourneux Y; Ardouin P; Gouyette A; Fournier JP; Roger P
Anticancer Res; 1988; 8(6):1419-22. PubMed ID: 3218975
[TBL] [Abstract][Full Text] [Related]
6. 1,3-bis(2-chloroethyl)-1-nitrosourea (bcnu) and other nitrosoureas in cancer treatment: a review.
Carter SK; Schabel FM; Broder LE; Johnston TP
Adv Cancer Res; 1972; 16():273-332. PubMed ID: 4563045
[No Abstract] [Full Text] [Related]
7. Modification of L1210 cell nuclear proteins by 1-methyl-1-nitrosourea and 1-methyl-3-nitro-1-nitrosoguanidine.
Pinsky SD; Tew KD; Smulson ME; Woolley PV
Cancer Res; 1979 Mar; 39(3):923-8. PubMed ID: 427780
[No Abstract] [Full Text] [Related]
8. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
Mulcahy RT; Siemann DW
Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
[TBL] [Abstract][Full Text] [Related]
9. [Disruption of DNA synthesis and structure of mouse L1210 leukemia cells, sensitive and resistant to 1-methyl-1 nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea in vivo].
Kukushkina GV; Peretolchina NM; Minenkova EA; Verovskiĭ VN; Sof'ina ZP
Biokhimiia; 1984 Jul; 49(7):1189-98. PubMed ID: 6477985
[TBL] [Abstract][Full Text] [Related]
10. [Sulfur-containing nitrosoureas].
Tang WC; Schmid J; Fiebig HH; Eisenbrand G
Yao Xue Xue Bao; 1986 Jul; 21(7):502-9. PubMed ID: 3811939
[No Abstract] [Full Text] [Related]
11. 3-(Tetraacetyl glucopyranos-2-yl)-1-(2-chloroethyl)-1-nitrosourea, an antitumor agent with modified bone marrow toxicity.
Schein PS; McMenamin MG; Anderson T
Cancer Res; 1973 Sep; 33(9):2005-9. PubMed ID: 4353476
[No Abstract] [Full Text] [Related]
12. Relationship of structure to anticancer activity and toxicity of the nitrosoureas in animal systems.
Johnston TP; Montgomery JA
Cancer Treat Rep; 1986 Jan; 70(1):13-30. PubMed ID: 2935250
[No Abstract] [Full Text] [Related]
13. Clinical comparison of the nitrosoureas.
Wasserman TH; Slavik M; Carter SK
Cancer; 1975 Oct; 36(4):1258-68. PubMed ID: 1100221
[TBL] [Abstract][Full Text] [Related]
14. Interrelationships of some chemical, physicochemical, and biological activities of several 1-(2-haloethyl)-1-nitrosoureas.
Wheeler GP; Bowdon BJ; Grimsley JA; Lloyd HH
Cancer Res; 1974 Jan; 34(1):194-200. PubMed ID: 4809457
[No Abstract] [Full Text] [Related]
15. [Effect of N-nitroso-N-methylurea on DNA and RNA synthesis in cells of liver and spleen tumors in leucosis L-1210].
Sokolova IS; Ostrovskaia LA; Bunto TV; Gorbacheva LB
Vopr Onkol; 1976; 22(10):61-6. PubMed ID: 1014495
[TBL] [Abstract][Full Text] [Related]
16. Antitumor structure-activity relations. Nitrosoureas vs. L-1210 leukemia.
Hansch C; Leo A; Schmidt C; Jow PY; Montgomery JA
J Med Chem; 1980 Oct; 23(10):1095-101. PubMed ID: 7420354
[TBL] [Abstract][Full Text] [Related]
17. Contributions of nitrosoureas to cancer treatment.
Mitchell EP; Schein PS
Cancer Treat Rep; 1986 Jan; 70(1):31-41. PubMed ID: 3002621
[No Abstract] [Full Text] [Related]
18. Radiation synergism by repair-inhibiting nitrosoureas in L1210 cells.
Kann HE; Blumenstein BA; Petkas A; Schott MA
Cancer Res; 1980 Mar; 40(3):771-5. PubMed ID: 7471095
[No Abstract] [Full Text] [Related]
19. [Kinetic study of the effect of N-nitroso-N-alkylurea on the development of leukemia L1210].
Ostrovskaia LA; Sokolova IS; Gorbacheva LB
Vopr Onkol; 1977; 23(3):59-63. PubMed ID: 898797
[TBL] [Abstract][Full Text] [Related]
20. Current status of new agents.
Carter SK
Cancer Chemother Rep 3; 1972 May; 3(1):33-47. PubMed ID: 4116662
[No Abstract] [Full Text] [Related]
[Next] [New Search]
